Literature DB >> 9480815

Peroxisome biogenesis disorders: identification of a new complementation group distinct from peroxisome-deficient CHO mutants and not complemented by human PEX 13.

N Shimozawa1, Y Suzuki, Z Zhang, A Imamura, T Tsukamoto, T Osumi, K Tateishi, K Okumoto, Y Fujiki, T Orii, P G Barth, R J Wanders, N Kondo.   

Abstract

Ten complementation groups of generalized peroxisome biogenesis disorders (PBD), (excluding rhizomelic chondrodysplasia punctata) have been identified using complementation analysis. Four of the genes involved have been identified using two different methods of (1) genetic functional complementation of peroxisome deficient CHO cell mutants and (2) homology searches for human dbEST, based on yeast genes involved in peroxisome biogenesis (PEX genes). We report here the first identification of a new complementation group which is genetically different from peroxisome deficient CHO mutants. There were no complementations by the human PEX 13 gene. The nature of the related gene is being investigated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480815     DOI: 10.1006/bbrc.1997.8067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency).

Authors:  R J Wanders; P A Mooijer; C Dekker; Y Suzuki; N Shimozawa
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders.

Authors:  Y Liu; J Björkman; A Urquhart; R J Wanders; D I Crane; S J Gould
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

4.  The peroxin pex3p initiates membrane assembly in peroxisome biogenesis.

Authors:  K Ghaedi; S Tamura; K Okumoto; Y Matsuzono; Y Fujiki
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

5.  Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders.

Authors:  Paola Borgia; Simona Baldassari; Nicoletta Pedemonte; Ebba Alkhunaizi; Gianluca D'Onofrio; Domenico Tortora; Elisa Calì; Paolo Scudieri; Ganna Balagura; Ilaria Musante; Maria Cristina Diana; Marina Pedemonte; Maria Stella Vari; Michele Iacomino; Antonella Riva; Roberto Chimenz; Giuseppe D Mangano; Mohammad Hasan Mohammadi; Mehran Beiraghi Toosi; Farah Ashrafzadeh; Shima Imannezhad; Ehsan Ghayoor Karimiani; Andrea Accogli; Maria Cristina Schiaffino; Mohamad Maghnie; Miguel Angel Soler; Karl Echiverri; Charles K Abrams; Pasquale Striano; Sara Fortuna; Reza Maroofian; Henry Houlden; Federico Zara; Chiara Fiorillo; Vincenzo Salpietro
Journal:  Orphanet J Rare Dis       Date:  2022-07-19       Impact factor: 4.303

6.  Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.

Authors:  M Honsho; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

Review 7.  Biology of senescent liver peroxisomes: role in hepatocellular aging and disease.

Authors:  J Youssef; M Badr
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.